Zuellig Pharma
↗Singapore, Singapore
Zuellig Pharma is the leading healthcare services provider in Asia, offering a comprehensive suite of services including distribution, commercialization, and clinical trial support. The company serves as a vital link between global pharmaceutical manufacturers and over 350,000 medical facilities across 13+ Asian markets.
Beyond traditional logistics, Zuellig Pharma has pivoted toward digital health and patient-centric solutions, utilizing blockchain (eZTracker) for supply chain integrity and data analytics to improve healthcare accessibility. It is a multi-billion dollar enterprise with a century-long heritage in the Asia-Pacific region.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Healthcare Services & Distribution
SIZE & FINANCIALS
Employees:10000+
Revenue:$13B-$15B
Founded:1922
Ownership:private
Status:operating
FUNDING
Stage:Late Stage
Total Raised:Undisclosed
Investors:Temasek Holdings, Zuellig Group
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Service Provider)
Modalities:Small molecule, mAb, Vaccines, Cell therapy logistics
Active Trials:3000
Trial Phases:Phase 1: 500 | Phase 2: 1000 | Phase 3: 1200 | Phase 4: 300
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Zuellig Group
Subsidiaries:ZP Therapeutics, MiCare, eZTracker
Key Partnerships:Lundbeck (CNS commercialization), Bayer (Consumer Health), Eli Lilly (Diabetes/Obesity distribution), Haleon
COMPETITION
Position:Leader
Competitors:DKSH, IDS Medical Systems, Cardinal Health, AmerisourceBergen
LEADERSHIP
Key Executives:
John Graham - CEO
Evasio Barbero - CFO
Board Members:John Graham, Luis Enriquez
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Zuellig Pharma. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.